Analyst Upgrades

• Cree (CREE) and Rubicon Technology (RBCN) to buy from neutral at Merriman.
• Children's Place (PLCE) to outperform from market perform at BMO Capital.
• Lockheed Martin (LMT) to neutral from underperform at BofA/Merrill.
• Copano Energy (CPNO) to outperform from market perform at Morgan Keegan.
• Motorola Mobility (MMI) to neutral from reduce at Nomura.
• Parker-Hannifin (PH) to buy from hold at KeyBanc.
• Akamai (AKAM), ShoreTel (SHOR), AMB Property (AMB) and ProLogis (PLD) to buy from hold at Stifel Nicolaus.

Analyst Upgrades

• Parker-Hannifin (PH) to buy from hold at Deutsche Bank.
• JDSU (JDSU) to buy from hold at Citigroup.
• Noble Corp. (NE) to overweight from neutral at JPMorgan.
• Cerner (CERN) to buy from hold at Auriga.
• Cintas (CTAS) to outperform from neutral at RW Baird.
• American States Water (AWR) to buy from hold at Brean Murray.
• National Semiconductor (NSM) and Texas Instruments (TXN) to positive from neutral at Susquehanna.
• Lululemon (LULU) to buy from hold at ThinkEquity.
• DuPont Fabros (DFT) to top pick from outperform at RBC Capital.

The earnings season ramps up this week. Analysts polled by Thomson Reuters foresee strong reports from such big names as Apple (AAPL), eBay (EBAY), IBM (IBM), General Electric (GE), Google (GOOG), Schlumberger (SLB) and Southwest Airlines (LUV). And fast on the heels of last week's big earnings beat from JPMorgan Chase (JPM), there will be plenty more results from the financial sector to peruse this week.

Among the financials expected to post double-digit earnings growth this week are Capital One Financial (COF), Morgan Stanley (MS), SLM Corp. (SLM) and U.S. Bancorp (USB), but the week's biggest earnings winner may be Wells Fargo (WFC).

Analyst Upgrades

• NYSE Euronex (NYX) to conviction buy from neutral at Goldman.
• General Dynamics (GD) to buy from hold at Citigroup.
• Deere (DE), Parker-Hannifin (PH) and ExlService (EXLS) to overweight from neutral at JPMorgan.
• Aflac (AFL) to outperform from market perform at FBR Capital.
• Wynn Resorts (WYNN) to buy from neutral at Janney Capital.
• Amdocs (DOX) to buy from neutral at UBS.
• Juniper (JNPR) to buy from hold at ThinkEquity.
• Rudolph Tech (RTEC) and KLA-Tencor (KLAC) to perform from underperform at Oppenheimer.
• Hershey (HSY) and Pinnacle Entertainment (PNK) to outperform from market perform at Wells Fargo.
• Spirit AeroSystems (SPR) to equal weight from underweight at Morgan Stanley.
• Micron (MU) to outperform from neutral at RW Baird.

Analyst Upgrades

• General Electric (GE) and Barclays (BCS) to buy from neutral at UBS.
• Warnaco (WRC) to outperform from market perform and Melco Crown (MPEL) to market perform from underperform at Wells Fargo.
• Parker-Hannifin (PH) and Emerson Electric (EMR) to buy from neutral at Goldman.
• AMD (AMD) to buy from neutral at Nomura.
• Novellus (NVLS) and Sherwin-Williams (SHW) to equal weight from underweight at Morgan Stanley.
• OpenTable (OPEN) to outperform from market perform at Morgan Keegan.
• Skilled Healthcare (SKH) to buy from hold at Jefferies.
• Lear (LEA) to overweight from equal weight at Barclays.
• Adobe (ADBE) to buy from neutral at BofA/Merrill.

If you are looking for clues telling you which stocks have a good chance of increasing in value, you might want consider watching what insiders are doing. After all, talk is cheap, but when insiders put their own money on the line, you should sit up and take note.

Scientific Games Corp. (SGMS) topped the insider-buying charts for the week ending July 9th as insiders snapped up 4,387,000 shares of company stock at a market value of $38,159,298. During the past six months, insiders have increased their overall holdings in the company by 74.21% and now own 2.05% of SGMS stock.

Eaton Corp. (ETN) has been on a tear -- rising from $85 to $95 -- since it smashed Wall Street estimates with its latest earnings announcement in late October, and it looks like the gains are going to continue.

Goldman Sachs just upgraded Eaton from a neutral rating and put the company on its conviction buy list -- moving its price target for the stock from $103 to $117.

Goldman was originally expecting Eaton to earn $7.35 per share in 2011 and $8.90 in 2012, but the firm has now updated its EPS expectations to $7.80 in 2011 and $9.40 in 2012.

Analyst Upgrades

• Canaccord believes growth in DigitalGlobe's (DGI) commercial business will be a catalyst for shares. The firm upgraded shares to buy from hold and has a $38 price target on the stock.
• Standpoint upgraded Abercrombie & Fitch (ANF) to accumulate from hold based on valuation. The firm has a $47 target on the stock.
• Morgan Keegan upgraded Open Text (OTEX) to outperform from market perform based on the company's strong FY2011 EPS outlook.
• Devon Energy (DVN) was upgraded to overweight from equal weight at Morgan Stanley.
• Magna (MGA) was upgraded to outperform from sector perform at RBC Capital.
• EnCana (ECA) was upgraded to outperform from neutral at Macquarie.

After the crunch of quarterly reports over the past two weeks, things will be fairly quiet on the earnings front Monday. Analysts polled by Thomson Reuters expect Allergan (AGN), Loews (L) and Vulcan Materials (VMC) to report higher second quarter earnings, compared to a year ago. Oshkosh (OSK) is anticipated to have swung to a profit from a year-ago loss, and Humana (HUM) is expected to post earnings per share (EPS) about the same as last year.

The crush of quarterly reports is back on come Tuesday, with Coach (COH), Harris (HRS), MasterCard (MA), Molson Coors (TAP), Pfizer (PFE), Priceline.com (PCLN) and Whole Foods (WFMI) among those expected to post earnings growth. The highlight of the day though may be Parker Hannifin's (PH) fiscal fourth-quarter results.

Analyst Upgrades

• Deutsche Bank upgraded Intercontinental Exchange (ICE) to buy from hold on valuation following the recent pullback in shares. The firm raised its target price on shares to $113 from $108.
• UBS upgraded General Dynamics (GD) to buy from neutral based on improved defense risk profile and stabilization in the business jet market. The firm raised its target to $80 from $70.
• FBR Capital upgraded SunTrust (STI) to outperform from market perform on expectations that regional banks will outperform the large money center banks in this environment. The firm raised its price target on shares to $28 from $22.
• SAP AG (SAP) was upgraded to buy from neutral at BofA/Merrill.
• Thomson Reuters (TRI) was raised to buy from hold at Citigroup.
• Rosetta Resources (ROSE) was upgraded at Wells Fargo to outperform from market perform.

Analyst upgrades:

• Keefe Bruyette upgraded Blackstone Group (BX) to outperform from market perform following the company's Q3 results and maintains an $18.50 price target on shares.
• Baird upgraded Astec (ASTE) to outperform from neutral citing relative valuation and upside from new multi-year U.S. highway funding legislation. The firm raised its target to $33 from $27.
• Goldman upgraded Abercrombie & Fitch (ANF) to conviction buy from neutral citing "significant" long-term growth drivers that include international growth. The firm raised its target to $45 from $36.
• Ariad Pharmaceuticals (ARIA) was upgraded to overweight from neutral at JPMorgan.
• Energizer (ENR) was upgraded to overweight from equal weight at Morgan Stanley.
• AstraZeneca (AZN) was upgraded to buy from hold at RBS.

Analyst upgrades:

• Goldman upgraded SanDisk (NASDAQ: SNDK) to Buy from Neutral and raised their target to $22 from $16 citing the renegotiated royalty agreement with Samsung.
• Goldman also upgraded Starwood Hotels (NYSE: HOT) to Buy from Sell and raised their target to $27 from $11 citing strong operating leverage as RevPAR recovers.
• KeyBanc upgraded Werner Enterprises (NASDAQ: WERN) to Hold from Underweight citing a recent improvement in freight demand.
• J.C. Penney (NYSE: JCP) was upgraded to buy from Underperform at Banc of America/Merrill.
• Savvis (NASDAQ: SVVS) was raised to Outperform from Perform at Oppenheimer.
• Sanofi-Aventis (NYSE: SNY) was upgraded at Citigroup to Buy from Hold.

TheStreet.com's Jim Cramer says that before you buy into the conventional wisdom, you should consider these counter-arguments.

Sometimes it pays to know the consensus thinking of the big boys, the smart boys who trade every day. So let's detail it before we critique it:

1. Someday the companies that report bad earnings are going to start going down again. This is the Parker Hannifin (NYSE: PH) (Cramer's Take) dilemma I keep alluding to, a company that skyrockets on terrible numbers no matter how you cut it.

2. The market will now recognize that the stress test is a big joke, everything's a phony, and the banks will fold again. Roubini's right; Geithner's a lightweight.

Analyst upgrades:

• Deutsche Bank upgraded AmerisourceBergen (NYSE:ABC) to Buy from Hold on valuation as it views the risk/reward as favorable at current levels. Deutsche raised its target price to $41.50 from $38.
  
• FBR Capigal upgraded Charlotte Russe (NASDAQ:CHIC) to Outperform from Market Perform following the company's Q2 results on expectations merchandise improvements and cost-cutting efforts will drive continued margin expansion. The firm raised its target on shares to $15 from $10.
  
• Oppenheimer upgraded Fidelity National (NYS:FIS) to Outperform from Perform as it believes the Metavante (MV) acquisition makes strategic sense and the stock's risk/reward is favorable. The firm's target price is $25.
• First American (NYSE:FAF) was upgraded to Outperform from Market Perform at Keefe Bruyette.
  
• Nokia (NYSE:NOK) was raised to Neutral from Underweight at JP Morgan.
  
• Parker-Hannifin NYSE:(PH) was lifted at Wachovia to Outperform from Market Perform.

Alcoa Inc. (NYSE: AA) started off the new earnings season with disappointing results that helped to stifle the recent rally. Was that enough of a sign of what's to come? No, probably not. But the earnings reports start to fly in earnest this week, which should provide a more detailed picture of the state of things.

Analysts surveyed by Thomson Reuters anticipate that some of the biggest names will prove to be holding their own. Google Inc. (NASDAQ: GOOG) is expected to post a profit of $4.91 per share, marginally higher than a year ago, and Johnson & Johnson's (NYSE: JNJ) expected $1.22 per share profit is slightly lower year over year. Even Mattel Inc.'s (NYSE: MAT) estimated loss of $0.13 per share is the same as in the year-ago period.